<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>ACKNOWLEDGMENTS</title>
 <p>This work was supported by the National Natural Science Foundation of China (81788101), the Ministry of Science and Technology of China (2015CB553406), the National Natural Science Foundation of China (81490531), and the CAMS Innovation Fund for Medical Sciences (2017-I2M-1-009).</p>
 <p>We declare that we have no competing interests.</p>
 <p>C. Jiang conceived the project. C. Jiang and N. Jin designed the study and analyzed the data. C. Zhang performed the biosafety level 3 experiments employing the genomewide RNAi screen, with assistance from Q. Zhang, Q. Liu, H. Lu, and X. Li. C. Zhang and Y. Qin performed cell viability and the biosafety level 3 experiments in mice. Y. Zhang and D. Shang analyzed the pathology results. C. Zhang, Y. Zhang, and D. Shang screened the candidate drugs. F. Huang led the bioinformatic analysis with assistance from C. Zhang. C. Zhou helped analyze the data. F. Huang, C. Zhang, Y. Zhang, and C. Jiang wrote the manuscript.</p>
</ack>
